# Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis.

> **NCT05031481** · PHASE2 · WITHDRAWN · sponsor: **EMS**

## Conditions studied

- Vulvovaginal Candidiasis

## Interventions

- **DRUG:** Venus 20 + 0,064
- **DRUG:** Venus 20 + 1
- **DRUG:** Venus 20 + 4
- **DRUG:** Butoconazole nitrate

## Key facts

- **NCT ID:** NCT05031481
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-07-01
- **Primary completion:** 2023-12
- **Final completion:** 2024-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2022-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05031481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05031481, "Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05031481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*